ALFREDO
TAGARRO GARCIA
PROFESOR DOCTOR
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (15)
2023
-
Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Anales de Pediatria, Vol. 98, Núm. 3, pp. 213-227
-
Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Atencion Primaria, Vol. 55, Núm. 6
-
Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 111-122
2022
-
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children
European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115
-
Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens
Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382
-
Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection
Journal of Pediatrics, Vol. 241, pp. 126-132.e3
-
Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study
Thorax, Vol. 77, Núm. 12, pp. 1193-1201
-
Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort
Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768
-
Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain
Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 10, pp. 471-473
2021
-
Prevalence of thrombotic complications in children with SARS-CoV-2
Archives of Disease in Childhood, Vol. 106, Núm. 11, pp. 1129-1132
-
Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)
Anales de Pediatria, Vol. 94, Núm. 2, pp. 116.e1-116.e11
-
Treatment of Multisystem Inflammatory Syndrome in Children
New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22
2020
-
Growth Patterns in Children with Congenital Cytomegalovirus Infection
Pediatric Infectious Disease Journal, pp. 1230-1235
2017
-
Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants with Congenital Infection: Associations with Clinical Evaluation at Birth and Implications for Follow-up
Clinical Infectious Diseases, Vol. 64, Núm. 10, pp. 1335-1342